Company news

Evofem Biosciences, Inc. news in 2025

Evofem Biosciences, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE

November 21, 2025

Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update

November 13, 2025

Evofem Announces Voting Results from Special Meeting of Stockholders

October 20, 2025

Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates

October 1, 2025

Evofem Biosciences Honors World Contraception Day

September 26, 2025

Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms

September 11, 2025

Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting

September 9, 2025

Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law

August 21, 2025

FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis

August 19, 2025

Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update

August 14, 2025

Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference

August 5, 2025

Phexxi -- A Non-Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy

July 15, 2025

Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store

June 23, 2025

Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting

June 11, 2025

Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1

May 21, 2025

Evofem Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025

Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

April 15, 2025

Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates

April 14, 2025

Evofem Biosciences to Present at Emerging Growth Conference

April 14, 2025

Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

March 26, 2025

Evofem Reports Fourth Consecutive Year of Net Sales Growth

March 24, 2025

Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO

February 12, 2025

Decks in 2025